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Living with and beyond cancer is a highly personal experience that can affect many parts of 
an individual’s life (Independent Cancer Taskforce, 2015). Advances in prevention, early 
detection, and treatment means that people are now living with the effects of their cancer 
diagnosis for longer, and living with and beyond cancer is becoming an increasingly common 
experience (Foster and Fenlon, 2011). The experience of living with and beyond cancer 
moves away from cancer survivorship (which implies a definite conclusion to cancer) as the 
dominant discourse in cancer care (Foster et al, 2018). Although the concept of living with 
and beyond cancer is evident in international policy and literature, supporting people to live 
with and beyond cancer is complex because there are inconsistencies in understanding    
(Le Boutillier et al, 2019). Research is uncovering individual experiences of those living with 
cancer (Donovan and Flynn, 2007, Burles and Holtslander, 2013), but it has been argued 
that this idiographic nature of living with and beyond cancer (i.e. an individual person, with 
one type of cancer, in their specific context) has limited impact and reach (Larkin, 2019, 
Palmer, 2010). Phenomenology is concerned with part-whole relationships; that is, 
identifying the essential structure of experiences and the constituent parts that go to shape 
those experiences (Tomkins, 2010). A recent systematic review and narrative synthesis that 
developed an overarching conceptual framework to describe the patient experience of living 
with and beyond cancer has gone some way to identifying shared experiences (Le Boutillier 
et al., 2019). However, primary research that focuses on exploring how individual 
experiences (the parts) may be relevant to others who are living with and beyond cancer (the 
whole) is limited, with only four of the 73 included studies focusing on experiences across 
cancer types (Foley et al., 2006, Hubbard and Forbat, 2012, Grimsbo et al., 2011, de 
Guzman et al., 2013). It is important that shared experiences of living with and beyond 
cancer are identified in order to design effective services that address common unmet 
needs, to inform quality improvement, and to ensure that cancer support and resources are 
allocated effectively (Tsianakas et al., 2012a). Understanding shared experiences of those 
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who are living with and beyond cancer informs the provision of care across the cancer 
experience, by identifying who needs what support, and how this support is best delivered 
(Foster et al., 2018). Providing services built on shared experience also addresses the need 
to reduce variation in treatment, outcomes and experience within and between different 
cancer types (Independent Cancer Taskforce, 2015). 
The primary aim of this study was to contribute to the understanding of what it means for 
individuals to live with and beyond cancer. The second aim was to complement idiographic 
knowledge with multiple perspectives from a particular cohort of participants who are living 
with or beyond breast, prostate, or colorectal cancer to explore how individual experiences 
may be relevant to others.  
METHODS 
Study design 
The study was designed in two stages: 1) semi-structured interviews were conducted to 
explore individual experiences, and 2), focus groups were used to explore how individual 
experiences may be relevant to others who are living with and beyond cancer. The study 
used interpretive phenomenological analysis (IPA) as described by Smith et al. (2009). IPA 
was selected for this study because it focuses on exploring the meaning of, and how people 
make sense of their life experiences (Smith et al., 2009), and has been used successfully in 
other research investigating lived experiences of cancer (Maguire et al., 2014, Williams and 
Jeanetta, 2015, Phillips et al., 2017, McGeechan et al., 2018).  
IPA is based on phenomenology, that is the study of the lived meaning of an experience, 
and hermeneutics, the art and science of interpretation or meaning. IPA follows an 
idiographic approach with detailed and nuanced analysis of each case before examining the 
convergence and divergence between participants’ experiences (Smith et al., 2009). IPA 
studies have typically been conducted on small sample sizes to allow for detailed case-by-
case analysis of individual experiences about the perceptions and understandings of each 
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participant (Smith et al., 2009). However, focus groups are now emerging in IPA studies and 
are used to extend the commitment to idiography by combining and co-constructing lived 
experience (Larkin, 2019, Phillips et al., 2016, Palmer, 2010, Githaiga, 2014). To our 
knowledge, this is the first study that extends the use of IPA methodology by integrating 
interview and focus group data, and by exploring the concept of living with and beyond 
cancer across cancer types. The study design is illustrated in Figure 1.  
 
Figure 1: Study design that combines individual and group-level data across cancer types 
Data collection 
Data collection was conducted at Imperial College Healthcare NHS Trust (ICHT). In stage 1, 
eighteen semi-structured interviews were carried out with patients who had received primary 
treatment for breast (n=6), prostate (n=6) or colorectal (n=6) cancer. In stage 2, six focus 
groups with different patients who had received primary treatment for breast (n=13), prostate 
(n=5) or colorectal (n=8) cancer were conducted. The decision to explore the lived 
experiences of breast, prostate and colorectal cancer was made because they are among 
the most common cancers in the UK (Independent Cancer Taskforce, 2015). 
Participants were selected on the basis that they could offer a particular perspective on living 
with and beyond cancer (Smith et al., 2009) - those who had received primary treatment for 
breast cancer, prostate cancer and colorectal cancer and who had been risk-stratified to low-
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risk open-access follow-up, also known as self-managed stratified follow-up. The aim was 
not to have a completely homogenous sample as is consistent with some IPA studies so that 
convergence and divergence could be examined within the sample. Participants were over 
18, proficient in English, and were based in London or able to travel to an ICHT site.  
Potential participants were first approached by a cancer support worker, and subsequently 
recruited by the lead author via the telephone, email or face-to-face. Informed consent to 
enter the study was sought from each participant only after a full explanation and information 
leaflet was given and time allowed for consideration. Signed participant consent was 
obtained. The right of each participant to refuse to participate without giving reasons was 
respected. All participants were free to withdraw from the study up to 14 days after 
participation without giving reasons and without prejudicing further treatment. The anonymity 
of participants is preserved here through the use of pseudonyms (Smith et al., 2009). 
In stage 1, interviews used flexible open-ended in-depth questions for early data collection to 
offer participants the opportunity to share their stories, thoughts, and feelings and to gather 
rich, detailed first-person accounts of their lived experiences of living with and beyond 
cancer. The interview schedule asked participants to describe what it means to live with and 
beyond cancer, in their own words, and explored factors that support (or hinder) people to 
live with and beyond cancer and is included in Online Data Supplement (ODS) 1. Interviews 
were conducted across ICHT sites by the lead author, lasted around one hour, and were 
audio recorded and transcribed verbatim. Where requested, transcripts were returned to 
participants for comment and correction.  
In stage 2, early findings from the interviews were presented to a wider group of participants 
in 90-minute focus groups for further theoretical exploration. The aim was to generate 
discussion by providing examples of what it might mean to live with and beyond cancer. 
Separate focus groups were conducted with patients who had received treatment for breast, 
prostate or colorectal cancer to allow perspectives to be shared with others with similar 
6 
 
treatment experiences (Morgan, 1997). Focus groups were led by CL, and were audio 
recorded and transcribed verbatim. The focus group topic guide focused on exploring 
whether the interview findings were representative to others as a shared experience of living 
with and beyond cancer and is included in ODS 2. 
 
Reflexive notes were kept after each interview and focus group, and during the interpretive 
stages of analysis, and a particular focus was given to the role of the researcher in co-
creating the meaning of participant’s experiences (Smith et al., 2009).  
Data Analysis 
Interpretive phenomenological analysis of the data was undertaken using the procedure 
outlined Smith et al (2009), whereby analysis is grounded in accounts of experience (Smith 
et al., 2009). IPA is an iterative inductive process that moves back and forth through various 
stages to ensure in-depth and systematic examination of participant’s experiences. A 
layered approach to analysis was adopted to explore the parts; that is individual idiographic 
accounts, and how individual idiographic accounts were relevant to others with breast, 
prostate, or colorectal cancer experiences. The analysis was then extended to explore the 
whole by investigating if and how group accounts across cancer types were relevant to 
others who are living with and beyond cancer. 
 
Data analysis began with individual-level case-by-case repeated re-reading of interview 
transcripts and re-listening of sound files to become immersed in the data. This was followed 
by note-making of descriptive, linguistic, and conceptual observations to produce an initial 
analysis of each interview transcript. NVivo QSR International qualitative analysis software 
(version 11) was used to manage the data in a way that supported data analysis 
(International, 2018). Line-by-line open coding was conducted, and individual extracts were 
coded under one or several themes to fully capture their meaning. An initial coding frame 
was drafted where themes were developed and connections across themes were explored. 
7 
 
Thematic similarities that were identified between interview participants were drawn together 
to form super-ordinate themes. 
 
The second phase of data analysis involved reading and re-reading each focus group 
transcript to make sense of individual experience as well as to make sense of the 
participants’ attempts to make sense of others experiences within the group. This involved 
moving between individual focus group participant coded accounts and the shared group 
narratives. Considerations were given to how participants agreed or disagreed, and how 
participants supported each other to share their stories. Effort was taken to explore where 
group elements contributed to developing themes as well as how the themes were 
meaningful to the members of the group (Tomkins, 2010, Palmer, 2010).  
Cross-case analysis of each interview and focus group was used to code themes, to identify 
patterns, and to develop a final coding framework representing multiple perspectives. To 
further explore relationships in the data, interview and focus group interpretations were re-
considered by conducting an additional iterative loop (Love, 2020). The iterative loop 
involved tabulating themes across data sources, allowing for individual and group-level 
comparisons of the final coding framework. This process also ensured the collective-level 
interpretation was not privileged over the individual (Tomkins, 2010).  
Data analysis occurred concurrently with data collection. The lead author directed the 
analysis. Multiple coding (CB and SA) was undertaken to reflect on and enhance the 
awareness of the coding approach, and to enhance rigour (Mays and Pope, 1995).   
Ethical approval 
The study was funded by Macmillan Cancer Support and hosted by Imperial College 
Healthcare NHS Trust. Ethical approval was obtained from the West Midlands - Black 






A total of 18 people with personal experience of living with and beyond cancer participated in 
interviews, and an additional 26 people who are living with and beyond cancer participated in 
focus groups. Their characteristics are shown in Table 1. 
Insert Table 1 here 
The mean age of participants was 67.0 years (range 38-82), and time since diagnosis 
ranged from less than one year to seven years. ODS 3 details additional interview participant 
characteristics and ODS 4 details additional focus group participant characteristics. Of those 
people contacted by the researcher (CL), 90% agreed to take part in an interview (two 
people declined) and 60% agreed to take part in a focus group (17 people declined 
participation).  
The findings presented here demonstrate the ways in which accounts from multiple 
perspectives relate to one another, how differences can co-exist, and the paper explores 
how the multiplicity adds to the analysis. The super-ordinate themes to emerge from the data 
were: the cancer shock, managing cancer and getting through, and getting over cancer. 
Participants’ narratives focused on temporal stages of living with and beyond cancer so each 
of the themes can be mapped into dealing with i) diagnosis, ii) treatment or iii) life after 
treatment. Online data supplement (ODS) 5 provides the full coding framework and Figure 2 




Figure 2: Visual representation of themes 
Participant accounts detailed how the experience of living with and beyond cancer starts out 
with cancer consuming a large space in life, and as time passes and treatment progresses, 
the cancer space becomes smaller and less important. However, it was noted that this is not 
always a straightforward process, often with ‘ups and downs’ (Elliott, colorectal group), and 
where cancer ‘is beside me… [I’m] carrying it… I’m not always looking beyond it’ (Helen, 
breast group). Rosa explained how ‘it’s from the fear to the acceptance and then the cloud’ 
with the concern of recurrence hanging over her (Rosa, breast interview). 
For others, cancer no longer took any place in their lives; their experience of living with and 
beyond cancer described as ‘a short period of my life that has been on hold [and] just a blip 
at that time’ (Rachel, breast interview); ‘an episode which is over and done with’ (Sebastian, 
colorectal interview); and ‘a compartmentalised part of life’ (Helen, breast group). 
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Complementing idiographic knowledge with multiple perspectives  
While individual accounts of living with and beyond cancer detailed features specific to each 
person’s experience, focus group discussions illustrated how participant life worlds interact 
and overlap, and emphasised that specific features are connected to shared perspectives 
between individuals and across cancer types. The range of breadth and depth captured in 
the focus group data contributed to and complemented the content of the themes. The 
following quote also illustrates the cohesion, support, and therapeutic nature of sharing 
experiences in a focus group interaction: 
Interviewer: ‘We’re going to start to wrap up now. 
Maria:   Yes, well, I enjoyed it, thank you for having me. 
Sienna: When are we going to meet again?  
Olivia:   We would want to meet again.’ 
 
Table 2 illustrates the distribution of super-ordinate themes across cancer types and 
between individual and group-level data. Quotes that illustrate shared focus group 
experiences across cancer types are included in ODS6, and ODS7 goes on to illustrate 
quotes across interview (idiographic) and focus group (collective) data for the breast cancer 
group. 
Insert Table 2 here 
Theme 1: The cancer shock   
The experience of discovering breast, prostate or colorectal cancer is a time of crisis. 
Interview participants spoke about the ‘terrible shock [and] sense of outrage’ (Samuel, 
prostate interview) of receiving a cancer diagnosis, and of being forced to consider a threat 
to their life: 
‘The first thing you think is, am I going to die from it?... When they tell you, ‘you got cancer’, 





Focus group participants built on the narrative and went on to discuss the loss of control and 
sense of disbelief at finding out about their cancer diagnosis, sharing stories of how ‘your 
whole world is turned upside down and the bottom of your world drops out’ (Olivia, breast 
group). The stigma and sympathy associated with a cancer diagnosis was also a shared 
concern across focus groups. Having prostate or colorectal cancer was described as 
‘embarrassing’ (Leo, prostate interview; David, colorectal group) and some with breast 
cancer did not want to be seen as a ‘cancer patient’ (Norah, breast interview; Annabelle, 
breast group). 
The cancer shock also involved coming to terms with having breast, prostate, or colorectal 
cancer. This was described as less complicated for those who received an early diagnosis, 
and who received their diagnosis in the right way at the right time. For Jack, it was the 
reassurance from health staff that everything would be okay:  
 
‘I am lucky that mine was caught early, dealt with, done and dusted… What I do 
remember, the consultant said, well I can tell you now, you have got prostate cancer. 
That’s the bad news. The good news, he said, it isn’t going to kill you. I can tell you 
that now. I thought, well that is good news, so from there I am completely relaxed 
about the whole business’ (Jack, prostate interview). 
 
The right way for other participants was the need for a practical conversation about what 
happens next: 
 
‘The doctor said, ‘Well the biopsy came back and its cancer’. And he was fantastic, 
he told me everything, but then the breast nurse takes you out to another room and 
starts all this hand on shoulder thing, and it’s almost like she was burying me there. 
And I’m thinking I don’t need this, I really needed someone to just tell me point blank 
this is what’s going to happen next, this is what you need, this is what the next step is 
(Annabelle, breast group). 
 
 
Each of the cancer groups spoke about how their mindset was instrumental in how they 
accepted and adjusted to their diagnoses: ‘It’s a person’s attitude and if you’ve got that 
attitude, “I’m going to sort this, I’m going to beat it” (George, prostate group). 
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Disease knowledge and experience also influenced participants’ ability to come to terms 
with their diagnosis. Other health needs often had more prominence in people’s lives, such 
as heart disease and diabetes:  
‘I mean, I get more follow up reaction from my heart bypass operation which was 
done in 2003. I am still arguing about whether I should take my statins. I mean, 
that’s much more part of my life – living with and beyond heart problems would be 
much more part of my life than cancer… ‘I have never seen it as the big awful big 
C… you do not have to die anymore’ (Jack, prostate interview).  
 
Cancer was also less of a shock for participants who knew people who had survived 
cancer and had seen friends go through it.  
‘I have two very close friends and one other friend who have had mastectomies, 
they are all doing incredibly well, I mean I think probably all of them have survived 
10 years, and so they are a very good role model for me. I mean with 2 of them I 
was very involved with their treatment, and recovery. So, it isn’t a subject I hadn’t 
thought about’ (Coral, breast interview). 
 
Finding out as much as possible about cancer and treatment options supported participants’ ability 
to adjust to their cancer diagnosis. Sources of support included: information from clinical staff, 
online, via Macmillan Cancer Support Centres, Maggie’s Centres, other local cancer centres and 
charities, and peer support: 
‘I think when you talk to people, they tell you their experience and then you get a 
bit of satisfaction thinking right he had cancer, he did this, and he is better. Let me 
do it, let me try’ (Ruth, colorectal interview). 
 
Participants also stated how they are forced to consider the impact on others when finding out 
about their breast, prostate, and colorectal cancer. Norah chose to conceal her diagnosis because 
she did not want people to feel sorry for her: 
‘I didn’t want to show my weakness because cancer is weakness, negative in life. I don’t 
want to show negative things in life. I don’t want them to say, ‘sorry you have cancer’ I don’t 
want their sympathy’ (Norah, breast interview).  
 
 
For some, sharing the diagnosis was a relief that allowed some individuals ‘to look a bit more 
forward’ (Irene, breast group) and for others it meant that the experience was less solitary stating 
‘we’re in this together’ (Felicity, breast group). Others preferred not to share their diagnosis 




Narratives shared in individual interviews generated more codes around coming to terms 
with cancer, while focus groups provided a depth to the discussion with participants 
exploring the range of shared influences among the group. Focus groups extended the 
discussion around whether to conceal or reveal, reporting a desire to protect others from 
burden, feeling scared for others and needing to stay strong to support others. Discussions 
also centred on the need for outside support for family members at the time of diagnosis:    
‘My husband never said anything, but I know he is feeling it. He is feeling it, he is carrying it 
with me, at the same time. I told the children, we have got two daughters, I told one but the 
other one is not well, so I couldn’t tell her, because that would worry her too much’ (Emma, 
colorectal group).  
 
 
Theme 2: Managing cancer and getting through  
Managing cancer (and getting through) was described as ‘just something you have to slog 
through’ (Coral, breast interview). Focus group participants spoke about the sense of 
urgency that came following diagnosis, and the fast pace at which they were engaged with 
the cancer treatment pathways.  
‘So, once everything’s happening, you’re just going with it, there is no other way, 
you can’t step back and think for long because this thing develops quick, you know, 
so you have to really make up your decision really quickly as you go to 
appointments and everything’ (Annabelle, breast group). 
 
Interview participants provided greater detail and went on to speak about their confidence in 
health staff, being involved in health care planning, and being informed about treatment 
options as a support for managing cancer: 
‘They basically put together a plan and said, ‘right well, radiotherapy for however 
many months…’ it was surgery at that point and chemo afterwards, bang, bang, 
bang, bang, bang. So, within 18 months or whatever it was, diagnosed, and out sort 
of thing. So, you couldn’t really ask for more than that’ (Paul, colorectal interview). 
 
For other interview participants, the dependence on health care and being ‘completely at the 
mercy of medical staff’ (Matthew, prostate interview) left a feeling of being lost, of feeling 
uncertain, and of feeling ‘like you are a number in the system’ (Alice, colorectal interview) or 
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of being excluded from conversations about care options; ‘we talked about chemo but 
dismissed it – well we didn’t really talk- I said to my consultant – this was my one criticism… 
I wasn’t really given much other options and I had looked into what the other options were’ 
(Jack, prostate interview). 
 
Managing cancer also involved dealing with the various physical, emotional, social, functional, and 
financial effects of treatment. Treatment was described as ‘a disgrace to the body’ (Ruth, colorectal 
interview) and the effects of treatment were described as ‘the additional side of cancer’ (Martha, 
breast group). Interview and focus group narratives focused on sharing the side effects of cancer 
treatments. Common experiences included tiredness, nausea and sickness, brain fog and impaired 
memory, neuralgia, poor sleep, fear of being cut short, and impaired sexual function. Scarlett, living 
with a colostomy bag had a profound impact on her life that left her feeling low and isolated: 
‘It’s a really bad experience. I was active all the time… and I had to stop working, it 
was awful, and also with my social life, I had to stop. Most of the time I had to be 
home because I was really down and because [of] the bags. I was so embarrassed. 
I had so many accidents with the bags… the bags would open up, the smell it was 
terrible’ (Scarlett, colorectal interview). 
 
Thomas spoke about the impact of his prostatectomy: 
 
‘I did ask, ‘how would this affect my sex life’ … He said, ‘well, we will do whatever 
needs doing’, and he did, and it has left me now, no sex life really (Thomas, 
prostate interview). 
 
For Amelia, managing cancer was influenced by a lack of support after being left to manage 
hormone therapy when radiotherapy ended: 
 ‘… and then your friends are, “Oh well, you’ve had your last [radiotherapy] 
appointment now” and so for me, I’m still actively in the middle of it but somehow 
the process has said, “You’ve ended it – okay you’ve got hormone therapy, but 
you’re over with it now”. I felt the system thought I was done with well before I 
thought I was actually over that immediate stage. I felt like I’d been chucked off a 
cliff or cut off, and I was still in the middle of it and the process was saying, “That’s 
your last day of radiotherapy, you’re done now” and that was quite a difficult thing’ 
(Amelia, breast group).  
 
Alongside managing the effects of treatment, participants described a persistent concern about 
recurrence, and of ‘living under the cancer shadow’ (Rosa, breast interview). This meant that some 
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people felt like life was ‘on hold’ (Rachel, breast interview) while they remained under surveillance 
‘waiting for my graduation’ (Rosa, breast interview). Interviews and focus groups described that the 
availability of peer support, faith-based support and social support was a helpful contributing factor 
when managing cancer:  
'...make sure you have the support from your family and friends... that's the big thing and 
not to think you can manage it on your own' (Rita, breast interview). 
 
Theme 3: Getting over cancer   
Participants noted that their perspective of living with and beyond cancer changed with time. For 
some, cancer and the experience of cancer treatment became a second chance, and a prompt to 
enjoy life again; for others it meant accepting limitations and that life would be different:  
‘… everything has changed because this disease or illness changes your life.  Now, I must 
accept that this is my destiny; I will have to live with it’ (David, colorectal group). 
 
Rosa felt that ‘I am still living with it even though it’s gone… it’s an invisible thing’ (Rosa, breast 
interview) and Helen stated: 'I have moved on with my life but taken my cancer experience with 
me. I’m a different person now’ (Helen, breast group). Some participants felt they were back to 
living their lives as before, and others felt they were still surviving. Life after cancer was described 
by many as living your ‘life as a result of treatment, not living with treatment, you’re living as a 
result of treatment’. (Max, prostate group). 
Rita questioned whether she might forget the impact of her cancer experience with time: 
 
'I mean, more than 20 years ago I had a hysterectomy but mostly when I am asked 
my medical history, I tend to forget that, so I don't know if that would be the same for 
breast cancer as the time goes by' (Rita, breast interview). 
 
Norah likened the crisis of cancer to other life experiences such as bereavement and loss. 
She explained how she had coped with divorce and parental death, and conceptualised 
cancer as another different time in life: 
‘So, everybody has different times in life. I divorced and I recover, and second 





Participants spoke about new priorities for life, and some felt thankful for their cancer experience 
and the support they had received. Matthew spoke about the confidence that he gained from 
dealing with cancer: 
‘I don’t quite know how to say it, it’s not a good thing that happened to me, but something 
that happened made me see things in a different way, in a better way… I see things in a 
different way now, a much more positive way. I am much more positive now than I ever 
was, definitely, when you come through this you’ve got to be positive. If I have come 
through this, I can come through anything’ (Matthew, prostate interview). 
 
DISCUSSION  
The first aim of this study was to contribute to the understanding of what it means to live with 
and beyond cancer. The findings consist of three super-ordinate themes: i) the cancer 
shock, ii) managing cancer and getting through, and iii) getting over cancer. Participants 
used time-based narratives to construct their stories about living with and beyond cancer so 
each of the themes can be largely mapped onto dealing with i) diagnosis, ii) treatment or iii) 
life after treatment.  
The findings compliment and align with existing literature on living with breast, prostate or 
colorectal cancer (Le Boutillier et al., 2019) (Rogers K et al., 2021). While lived experience 
narratives offer a linear account in keeping with the treatment timeline, psychosocial 
adjustment and transitioning is a dynamic process with ups and downs, peaks and troughs, 
and waves (Pascal J, 2010). A recent systematic review and narrative synthesis describes 
the lived experience of cancer from the patient perspective and identifies three inter-linked 
themes: Adversity, Restoration and Compatibility, resulting in the ARC framework (Le 
Boutillier et al., 2019). The three super-ordinate themes presented in our analysis can be 
accommodated by the ARC framework, offering a consistent understanding of the 
adjustment to living with and beyond cancer and reinforcing the usefulness of a framework 
for services (Smith, 2018, Hubbard and Forbat, 2012, de Guzman et al., 2013). For example, 
adversity is experienced in the cancer shock phase when dealing with the challenge of 
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receiving a diagnosis and a threat to life (Shaha and Cox, 2003, Ervik et al., 2010). 
Strategies used to confront the adversity include seeking information and finding out all you 
can (Obeidat et al., 2012, Boehmke and Dickerson, 2006). Equally, for some ‘adversity’ also 
happens during and after treatment (managing cancer and getting through and getting over 
cancer) where people describe having to deal with the effects of treatment and where ‘things 
are never going to be quite the same again’ ((Rogers K et al., 2021) p.5).  For others, the 
treatment phase might align with ‘restoration’, with efforts being supported by confidence 
and involvement in treatment, support from healthcare providers, and social support (Ervik et 
al., 2010, Jonsson et al., 2010, Williams and Jeanetta, 2015, McGeechan et al., 2018). 
Jonsson et al (2010) describe the process of adapting to life after treatment as ‘balancing a 
changed life situation’ (p.27) where people are getting over cancer (Jonsson et al., 2010). 
Like the ‘compatibility’ phase in the ARC framework, this highlights an altered sense of self 
and importance for some individuals to adjust to life with cancer after it’s gone (Brennan, 
2001, Rogers K et al., 2021). 
 
The second aim was to explore multiple perspectives from people who have received 
treatment for breast, prostate, or colorectal cancer. Although experiences of living with and 
beyond cancer are well documented, this study extended the use of IPA by integrating 
interview and focus group data, in order to complement idiographic knowledge with multiple 
perspectives. The value of diverging from traditional IPA methodology has been illustrated 
by exploring how individual experiences (the parts) may be relevant to others who are living 
with and beyond cancer (the whole) (Larkin, 2019). Collective experiences have allowed an 
opportunity to enrich individual accounts by building a complex picture of the parts and the 
whole across cancer types. While individual accounts of living with and beyond cancer 
detailed specific features, similarities in lived experience across individuals and cancer types 
were also identified; ‘the specifics are unique, but they are hung on what is shared and 
communal’ (p.38) (Smith et al., 2009). We propose that individual accounts offer the 
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foundation for personalised supportive cancer care (the parts) and the shared experiences 
provide a central overarching scaffold for developing service-level provision that ensures 
cancer support and resources are allocated effectively. 
 
Clinical implications  
First-hand experiences contribute to the understanding of living with and beyond cancer and 
this knowledge can be used to address people’s needs and to inform the design of support 
services, stratified pathways and goals of care (Independent Cancer Taskforce, 2015, Maher 
J et al., 2018). The findings confirm that living with and beyond cancer requires a continuum 
of care with the experience beginning at the point of receiving a cancer diagnosis and having 
no definitive endpoint; the disruption of illness means that life is adjusted, and people are 
forced to consider a ‘new normal’ (Costanzo et al., 2007). While it is vital that policy and 
practice initiatives continue to focus efforts on early diagnosis and treatment, it also 
important to acknowledge and respond to cancer as a chronic condition that requires long-
term supportive care (Rogers K et al., 2021). Therefore, an individualised and person-
centred approach to care that is offered within an overarching framework of care, from 
diagnosis to life after treatment, is required to ensure improved long-term quality of life for 
people who live with and beyond cancer (Cappiello et al., 2007). Within this framework, a 
holistic approach that addresses physical, emotional, social, functional, and financial support 
needs, that supports adjustment and transition, and that promotes quality of life is also 
required (Independent Cancer Taskforce, 2015, Maher J et al., 2018). 
 
Holistic assessments (such as the Holistic Needs Assessment in the United Kingdom) 
promote patient preference and offer the opportunity for clinicians to work in partnership with 
people who are living with and beyond cancer by offering supportive conversations on which 
to share decisions and to co-produce individualised care plans that address person-centred 
goals (Department of Health, 2012). This practice mirrors that of recovery support in mental 
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health services, where co-production is also emerging as a powerful model to support the 
active participation of individuals who use services (Le Boutillier et al., 2011, Batalden P, 
2018). This equal partnership working between staff and patients enhances existing health 
systems, for example collaborating and involving patients in cancer multi-disciplinary team 
meetings (Soukup et al., 2020). As people focus more on living with cancer after treatment, 
the need for long-term management is also becoming increasingly apparent. The NHS long-
term plan offers a comprehensive model of personalised care that promotes shared decision 
making and that empowers people by being involved in personalised care planning (NHS 
England, 2019). This requirement for ongoing personalised support mirrors that of other 
chronic conditions such as diabetes (Engstrom M.S. et al., 2016) and stroke (Burton C.R., 
2000). 
Research implications  
The novelty and diversity of the research methods used in this IPA study allowed for different 
research roles and interactions. Individual semi-structured interviews offered the opportunity 
for each participant to share their story, and to make sense of their experience in a one-to-
one research interaction. Rich, detailed first-person accounts of living with and beyond 
cancer were gathered and interpretations were developed using a dual hermeneutic process 
(the interpretive relationship between the researcher and participant, whereby the researcher 
attempts to make sense of the participant’s account and the participant in turn makes sense 
of their own experience) (Smith et al., 2009). 
Focus groups provided an opportunity for individual participants to share their experiences 
with other people who were also living with and beyond cancer. The group provided a space 
for participants to interactively understand each other’s experiences, and to co-construct 
shared experiences. Our experiences of using focus groups to collect data in this study 
reinforces previous research by Munday (2006) in that focus groups were a suitable method 
for individuals to work together to form a collective identity as a group who share common 
values and ways of understanding themselves and their world (Munday J, 2006). For some, 
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the focus group provided an opportunity to meet others with similar experiences for the first 
time. This connection provided benefit beyond research by providing a sense of belonging in 
becoming a collective (us cancer people). Sharing experiences also extended to providing 
advice based on personal experiences of i.e., what had helped in certain situations, and 
support among participants was offered beyond the context of the research. The common 
experience of having received treatment for breast, prostate or colorectal cancer brought 
individuals together, participants were able to support each other to share their stories and 
manage the flow of the discussion with very little interaction from the researcher. The group 
interaction allowed for a depth of exploration, and provided rich, detailed individual and 
group-level accounts of living with and beyond cancer. The change in the balance of power 
in the researcher - researched relationship has important implications, both for the social 
context of the study, and for the findings that has opened up a new way of understanding 
living with and beyond cancer (Yardley, 2000). Interpretations were developed using a 
multiple hermeneutic process where the interpretive relationship whereby each participant 
makes sense of their own experience, the researcher makes sense of each participant’s 
first-person account and of participants’ attempts to make sense of each other’s experiences 
(Montague, 2020).  
 
The preliminary interview analysis allowed for identification of areas for further theoretical 
exploration, and informed focus group data collection. Focus groups were used to provide 
feedback on the preliminary analysis, to check the direction of researcher interpretation, and 
to clarify assumptions. In  this  way,  focus groups provided  access  to  lived  experience,  
allowed  participants to reflect on their own thoughts and feelings, to reflect on their own 
experiences with others, and to consider the experiences of others. In this way, the addition 
of focus groups expanded the research process by providing a stronger basis for creating 
nuanced understanding. 
Study strengths and limitations  
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One strength of the study is the thorough and systematic application of interpretive 
phenomenological analysis. This commitment to methodological rigour provides depth and 
detail in our understanding of how living with and beyond cancer has been experienced 
(Yardley, 2000). Alongside, this study contributes to the understanding of what it means to 
live with and beyond cancer by complementing idiographic knowledge with multiple 
perspectives from a group of participants who are living with and beyond cancer. This 
preservation of diversity of IPA and the appreciation of inherent complexities of qualitative 
research complements more traditional methods and demonstrates the value of exploring 
multiperspectival IPA (Larkin, 2019). While some identify the complexity of multiple 
hermeneutics as a limitation, we highlight the benefit of moving around the hermeneutic 
circle to explore individual and group-generated accounts in order to add richness and 
robustness to IPA, and to make sense of living with and beyond cancer from the 
perspectives of all participants (Tomkins, 2010). However, it is important to note that the 
findings are specific to those selected from the open-access follow-up list and are not 
empirically generalisable. It is possible, however, to enhance transferability by describing the 
research context and assumptions, and by making connections between the analysis of 
participants accounts and claims in the extant literature (Elliott et al., 1999, Whittemore et al., 
2001). Further research can also explore whether the meaning of living with and beyond 
cancer expressed by participants in our study holds true for other groups who are not on the 
open access pathway. While this study extends IPA methodology, one challenge has been 
the amount of time required for the cross-case analysis of the accounts of 44 people who are 
living with and beyond cancer, making the scope large for a qualitative study. The analysis 
process has been very time-consuming but critical to the quality of the study.  
It is important to acknowledge the limitations of IPA. While IPA is attractive because of its 
applicability to understanding the meaning of living with and beyond cancer and its 
commitment to explore, describe, interpret, and situate the participants’ sense making of 
their experiences, questions have been raised as to whether the approach accurately 
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encapsulates the experiences and meanings of experiences or whether it more likely 
captures opinions of experience (Tuffour I, 2017). A further critique of IPA relates to the 
complexity of defining phenomenology. With the study’s IPA focus on how people make 
sense of their experience, it has been argued that this approach has more of a psychological 
and cognitive focus and is not consistent with a phenomenological perspective (van Manen 




The NHS is committed to providing personalised care in order to improve the quality of life, 
self-management, and patient satisfaction for people who are living with and beyond cancer 
(England, 2019). Understanding patient experience is fundamental to improving healthcare, 
so future research will be grounded in co-design and participatory inquiry (Heron and 
Reason, 1997). Sophisticated methods like experience-based codesign (EBCD) can be used 
to involve people who are living with and beyond cancer, and clinical staff to explore how 
what we know about living with and beyond cancer can be used to inform the co-design and 
evaluation of a structured conversation tool that supports personalised care planning for 
long-term cancer care (Bate and Robert, 2006). EBCD is a collaborative approach that 
brings stakeholders together to provide opportunities for patient involvement in decision 
making about care planning and can provide the potential for transformational change 
(Robert et al., 2015). EBCD has previously been used successfully to develop complex 
interventions for supportive cancer care (Tsianakas et al., 2012b). The care of the growing 
number of people living with and beyond cancer needs to be tailored to better support 
people facing consequences of their diagnosis and treatment both in the short and longer 
term. Future research to investigate and co-design an approach to improve personalised 





A call has been made to better understand the experiences of those who have completed 
primary cancer treatment (Foster and Fenlon, 2011, Fenlon et al., 2013) and to improve the 
long-term quality of life for people who live with and beyond cancer (Independent Cancer 
Taskforce, 2015). A key challenge for health services is the lack of clarity around what 
constitutes living with and beyond cancer. First-hand experiences contribute to the 
understanding of adjustment when faced with the adversity of living with and beyond cancer. 
This knowledge can be used to direct supportive cancer care and to ensure improved long-
term quality of life for people who live with and beyond cancer. The novel multi-perspective 
IPA design presented in this paper allows us to move beyond the idiographic to a more 
comprehensive and detailed view of Living with and Beyond Cancer.       
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